Critical studies of fenbendazole suspension (10%) against naturally occurring helminth infections in dogs.
D000284:Administration, Oral; D000818:Animals; D001562:Benzimidazoles / Q000008:administration & dosage*; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D005273:Fenbendazole / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D009349:Nematode Infections / Q000188:drug therapy / Q000662:veterinary*; D013535:Suspensions; D014201:Trematode Infections / Q000188:drug therapy / Q000662:veterinary*
D001562:Benzimidazoles; D013535:Suspensions; D005273:Fenbendazole